Literature DB >> 15037715

POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in alpha-DG.

D S Kim1, Y K Hayashi, H Matsumoto, M Ogawa, S Noguchi, N Murakami, R Sakuta, M Mochizuki, D E Michele, K P Campbell, I Nonaka, I Nishino.   

Abstract

Walker-Warburg syndrome (WWS) is a congenital muscular dystrophy associated with neuronal migration disorder and structural eye abnormalities. The mutations in the O-mannosyltransferase 1 gene (POMT1) were identified recently in 20% of patients with WWS. The authors report on a patient with WWS and a novel POMT1 mutation. Their patient expressed alpha-dystroglycan (alpha-DG) core protein, but fully glycosylated alpha-DG antibody epitopes were absent, associated with the loss of laminin-binding activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037715     DOI: 10.1212/01.wnl.0000115386.28769.65

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.

Authors:  Peng Zhang; Huaiyu Hu
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

2.  RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1.

Authors:  C A Dwyer; E Baker; H Hu; R T Matthews
Journal:  Neuroscience       Date:  2012-06-19       Impact factor: 3.590

3.  A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation.

Authors:  Tomoko Yamamoto; Yoichiro Kato; Noriyuki Shibata; Tatsuo Sawada; Makiko Osawa; Makio Kobayashi
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

4.  Role of protein O-mannosyltransferase Pmt4 in the morphogenesis and virulence of Cryptococcus neoformans.

Authors:  Gillian M Olson; Deborah S Fox; Ping Wang; J Andrew Alspaugh; Kent L Buchanan
Journal:  Eukaryot Cell       Date:  2006-12-01

Review 5.  The Dystrophin Complex: Structure, Function, and Implications for Therapy.

Authors:  Quan Q Gao; Elizabeth M McNally
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

6.  Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality.

Authors:  Tobias Willer; Belén Prados; Juan Manuel Falcón-Pérez; Ingrid Renner-Müller; Gerhard K H Przemeck; Mark Lommel; Antonio Coloma; M Carmen Valero; Martin Hrabé de Angelis; Widmar Tanner; Eckhard Wolf; Sabine Strahl; Jesús Cruces
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

7.  Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy.

Authors:  Peng Zhang; Yuan Yang; Joseph Candiello; Trista L Thorn; Noel Gray; Willi M Halfter; Huaiyu Hu
Journal:  Matrix Biol       Date:  2013-02-27       Impact factor: 11.583

Review 8.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15

9.  Retinal ectopias and mechanically weakened basement membrane in a mouse model of muscle-eye-brain (MEB) disease congenital muscular dystrophy.

Authors:  Huaiyu Hu; Joseph Candiello; Peng Zhang; Sherry L Ball; David A Cameron; Willi Halfter
Journal:  Mol Vis       Date:  2010-07-28       Impact factor: 2.367

10.  Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.

Authors:  Miao Yu; Yonglin He; Kejian Wang; Peng Zhang; Shengle Zhang; Huaiyu Hu
Journal:  Hum Gene Ther       Date:  2013-03       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.